Reading over yesterday's PR again, it looks like Generex is definitely going after both markets - here and China. The Chinese FDA will oversee the first clinical studies in China, and then presumably start dosing patients immediately. As soon as the vaccine is formulated, Generex will initiate FDA guided trials here.

The good news is that if China is administering a vaccine that is working, there is going to be immense pressure on the FDA to fast track approval here. Nothing else will be ready before Generex's vaccine, so we may really have a huge head start. And if our vaccine works, and works very well, it may be game over for everyone else.